# Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old

> **NCT02035696** · PHASE1,PHASE2 · COMPLETED · sponsor: **Seqirus** · enrollment: 671 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Trivalent influenza vaccine (TIVc)
- **BIOLOGICAL:** Trivalent influenza vaccine-licensed

## Key facts

- **NCT ID:** NCT02035696
- **Lead sponsor:** Seqirus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-06
- **Final completion:** 2014-12
- **Target enrollment:** 671 (ACTUAL)
- **Last updated:** 2018-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02035696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02035696, "Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02035696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*